Focal Segmental Glomerulosclerosis (FSGS)

Explore clinical trials studying Focal Segmental Glomerulosclerosis (FSGS). Study availability and eligibility vary by location and protocol.

7 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Focal Segmental Glomerulosclerosis (FSGS) trial results

Recruiting

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases

NCT07614477

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

Tianjin Medical University General Hospital Tianjin, Hebei, China

View Trial Details

Recruiting

SLIT ABS: Study on Patients With Autoimmune Podocytopathy

NCT07516964

Conditions: Disease, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations: Mayo Clinic Rochester, Minnesota, United States

Ludwig-Maximilians Universitat München, Germany

Ospedale Santa Maria Annunziata Bagno a Ripoli, Firenze, Italy

Meyer Children's Hospital IRCCS Florence, FIRENZE, Italy

View all 14 locations

View Trial Details

Recruiting

A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis

NCT07499700

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis (FSGS), +10 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Raman Spectroscopy Diagnosis of Kidney Diseases

NCT06760845

Conditions: Autoimmune Diseases, Diabetes Complications, Diabetes Mellitus, +18 more
Locations: Shandong Second Medical University. No.7166 Baotong West Street, Weifang, Shandong, 261053, China. Jinan, Shandong, China

View Trial Details

Completed

Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome

NCT07702981

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations: University Hospital of Ioannina Ioannina, Epirus, Greece

View Trial Details

Completed

Evaluation of the Pharmacokinetics and Safety of Inaxaplin in Participants With Mild or Moderate Hepatic Impairment

NCT06529796

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis (FSGS), +7 more
Locations: Division of Clinical Pharmacology, University of Miami Miami, Florida, United States

GCP Research St. Petersburg, Florida, United States

Texas Liver Institute San Antonio, Texas, United States

View Trial Details

Completed

A Study Evaluating the Relative Bioavailability and Food Effect of a Tablet Formulation of VX-147

NCT05955872

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis (FSGS), +7 more
Locations: ICON Salt Lake City Salt Lake City, Utah, United States

View Trial Details

Focal Segmental Glomerulosclerosis (FSGS)

Focal Segmental Glomerulosclerosis (FSGS) trial results

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases

SLIT ABS: Study on Patients With Autoimmune Podocytopathy

A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis

Raman Spectroscopy Diagnosis of Kidney Diseases

Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome

Evaluation of the Pharmacokinetics and Safety of Inaxaplin in Participants With Mild or Moderate Hepatic Impairment

A Study Evaluating the Relative Bioavailability and Food Effect of a Tablet Formulation of VX-147

Related conditions